Home > Annual Financials > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL Financial Statement Analysis
[BOM: 524636]

The Revenues of OXYGENTA PHARMACEUTICAL have increased by 3.37% YoY .
The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY.
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Annual Financial Results
[BOM: 524636]

StandaloneMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹113 Cr₹109 Cr₹40 Cr₹31 Cr₹61 Cr
Expenses ₹128 Cr₹119 Cr₹49 Cr₹38 Cr₹59 Cr
Operating Profit (Excl OI) ₹-15 Cr₹-9.81 Cr₹-9.70 Cr₹-7.12 Cr₹1.48 Cr
Other Income ₹0.29 Cr₹1.31 Cr₹0.04 Cr₹0.02 Cr₹0.01 Cr
Interest ₹4.83 Cr₹2.23 Cr₹1.59 Cr₹1.49 Cr₹0.93 Cr
Depreciation ₹2.32 Cr₹3.61 Cr₹2.66 Cr₹2.05 Cr₹1.59 Cr
Profit Before Tax ₹-22 Cr₹-14 Cr₹-14 Cr₹-11 Cr₹-0.49 Cr
Profit After Tax ₹-18 Cr₹-10 Cr₹-3.48 Cr₹-12 Cr₹-0.61 Cr
Earnings Per Share (Rs)₹-4.75₹-2.78₹-1.04₹-8.15₹-0.43
PAT Margin (%)-15.55-9.42-8.78-37.34-1.01
ROE(%)0.000.000.000.000.00
ROCE(%)-33.53-32.89-41.69-50.323.18
Total Debt/Equity(x)-2.57-2.43-2.77-1.47-1.51

Key Financials

Market Cap : ₹ 191.7 Cr
Revenue (TTM) : ₹ 134.8 Cr
Net Profit(TTM) : ₹ -13.6 Cr
EPS (TTM) : ₹ -3.7
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
OXYGENTA PHARMACEUTICAL 3.5% 10.8% -52.9%
SUN PHARMACEUTICAL INDUSTRIES -2.3% 3% 12.3%
DIVIS LABORATORIES 2.9% 22.7% 25.5%
TORRENT PHARMACEUTICALS -2.7% 2% 33.9%
CIPLA 0.1% 3% -7%
DR REDDYS LABORATORIES 2.4% -12.9% -9.1%
MANKIND PHARMA -1.6% -2.3% -4.8%
LUPIN -0.9% -2.7% 20.3%
ZYDUS LIFESCIENCES -1.8% -3.7% 11.7%


OXYGENTA PHARMACEUTICAL Revenues
[BOM: 524636]

Y-o-Y

3.37 %

5 Yr CAGR

16.89 %

Years Revenues % Change
Mar2026 ₹113 Cr
3.37
Mar2025 ₹109 Cr
175.72
Mar2024 ₹40 Cr
27.93
Mar2023 ₹31 Cr
-48.80
Mar2022 ₹61 Cr -


OXYGENTA PHARMACEUTICAL Operating Profit
[BOM: 524636]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2026 ₹-15 Cr
Negative
Mar2025 ₹-9.81 Cr
Negative
Mar2024 ₹-9.70 Cr
Negative
Mar2023 ₹-7.12 Cr
Negative
Mar2022 ₹1.48 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2026 -13.55%
Negative
Mar2025 -8.98%
Negative
Mar2024 -24.46%
Negative
Mar2023 -22.97%
Negative
Mar2022 2.44% -

OXYGENTA PHARMACEUTICAL Profit After Tax
[BOM: 524636]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2026 ₹-18 Cr
Negative
Mar2025 ₹-10 Cr
Negative
Mar2024 ₹-3.48 Cr
Negative
Mar2023 ₹-12 Cr
Negative
Mar2022 ₹-0.61 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2026 -15.55 %
Negative
Mar2025 -9.42 %
Negative
Mar2024 -8.78 %
Negative
Mar2023 -37.34 %
Negative
Mar2022 -1.01 % -

OXYGENTA PHARMACEUTICAL Earnings Per Share (EPS)
[BOM: 524636]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2026 ₹-4.75
Negative
Mar2025 ₹-2.78
Negative
Mar2024 ₹-1.04
Negative
Mar2023 ₹-8.15
Negative
Mar2022 ₹-0.43 -

OXYGENTA PHARMACEUTICAL Return on Capital Employed (ROCE)
[BOM: 524636]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2026 -33.53%
Negative
Mar2025 -32.89%
Negative
Mar2024 -41.69%
Negative
Mar2023 -50.32%
Negative
Mar2022 3.18% -

OXYGENTA PHARMACEUTICAL Share Price vs Sensex

Current Share Price : ₹51.8
Current MarketCap: ₹ 191.7 Cr
Updated EOD on :Aug 06,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

3.5%

10.8%

-52.9%

SENSEX

1.3%

1%

-2.9%

OXYGENTA PHARMACEUTICAL related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about OXYGENTA PHARMACEUTICAL Financials


How the annual revenues of OXYGENTA PHARMACEUTICAL have changed ?

The Revenues of OXYGENTA PHARMACEUTICAL have increased by 3.37% YoY .

How the Earnings per Share (EPS) of OXYGENTA PHARMACEUTICAL have changed?

The Earnings Per Share (EPS) of OXYGENTA PHARMACEUTICAL has decreased by Negative YoY .